Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Copelan

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
British Journal of Haematology|June 11, 2009
Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantationAnuj Mahindra, Brian Bolwell, Ronald Sobecks, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 23, 2008
Elevated ferritin is associated with relapse after autologous hematopoietic stem cell transplantation for lymphomaAnuj Mahindra, Brian Bolwell, Ronald Sobecks, et al.
Leukemia Research|October 31, 2006
High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myelomaDon M Benson, Patrick J Elder, Thomas S Lin, et al.
JCO Oncology Practice|April 21, 2020
Levine Cancer Institute Approach to Pandemic Care of Patients With CancerDerek Raghavan, Edward S Kim, S Jean Chai, et al.
Leukemia Research|August 11, 2010
Race and intensity of post-remission therapy in acute myeloid leukemiaAnna K Brady, Alex Z Fu, Marc Earl, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2010
Nonmyeloablative second transplants are associated with lower nonrelapse mortality and superior survival than myeloablative second transplantsBrian T Hill, Brian J Bolwell, Lisa Rybicki, et al.
Molecular Cancer Therapeutics|May 27, 2010
Decitabine maintains hematopoietic precursor self-renewal by preventing repression of stem cell genes by a differentiation-inducing stimulusZhenbo Hu, Soledad Negrotto, Xiaorong Gu, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|May 25, 2011
Cytomegalovirus reactivation after matched sibling donor reduced-intensity conditioning allogeneic hematopoietic stem cell transplant correlates with donor killer immunoglobulin-like receptor genotypeRonald M Sobecks, Medhat Askar, Dawn Thomas, et al.
British Journal of Haematology|July 22, 2014
SWOG0919: a Phase 2 study of idarubicin and cytarabine in combination with pravastatin for relapsed acute myeloid leukaemiaAnjali S Advani, Shannon McDonough, Edward Copelan, et al.
Cancer|June 22, 2010
Impact of weekend admissions on quality of care and outcomes in patients with acute myeloid leukemiaNelli Bejanyan, Alex Z Fu, Aleksandr Lazaryan, et al.
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
British Journal of Haematology|June 11, 2009
Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantationAnuj Mahindra, Brian Bolwell, Ronald Sobecks, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 23, 2008
Elevated ferritin is associated with relapse after autologous hematopoietic stem cell transplantation for lymphomaAnuj Mahindra, Brian Bolwell, Ronald Sobecks, et al.
Leukemia Research|October 31, 2006
High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myelomaDon M Benson, Patrick J Elder, Thomas S Lin, et al.
JCO Oncology Practice|April 21, 2020
Levine Cancer Institute Approach to Pandemic Care of Patients With CancerDerek Raghavan, Edward S Kim, S Jean Chai, et al.
Leukemia Research|August 11, 2010
Race and intensity of post-remission therapy in acute myeloid leukemiaAnna K Brady, Alex Z Fu, Marc Earl, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2010
Nonmyeloablative second transplants are associated with lower nonrelapse mortality and superior survival than myeloablative second transplantsBrian T Hill, Brian J Bolwell, Lisa Rybicki, et al.
Molecular Cancer Therapeutics|May 27, 2010
Decitabine maintains hematopoietic precursor self-renewal by preventing repression of stem cell genes by a differentiation-inducing stimulusZhenbo Hu, Soledad Negrotto, Xiaorong Gu, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|May 25, 2011
Cytomegalovirus reactivation after matched sibling donor reduced-intensity conditioning allogeneic hematopoietic stem cell transplant correlates with donor killer immunoglobulin-like receptor genotypeRonald M Sobecks, Medhat Askar, Dawn Thomas, et al.
British Journal of Haematology|July 22, 2014
SWOG0919: a Phase 2 study of idarubicin and cytarabine in combination with pravastatin for relapsed acute myeloid leukaemiaAnjali S Advani, Shannon McDonough, Edward Copelan, et al.
Cancer|June 22, 2010
Impact of weekend admissions on quality of care and outcomes in patients with acute myeloid leukemiaNelli Bejanyan, Alex Z Fu, Aleksandr Lazaryan, et al.
Pageof 9